HIV and pregnancy: realities of XXI century
https://doi.org/10.18699/SSMJ20220202
Abstract
The human immunodeficiency virus (HIV) continues to be a major global public health issue, having claimed 34 million lives so far. 38 million people are living with HIV around the world. 2 million of these people are children. The high medical, social and economic significance of HIV infection is determined by the widespread and severe course of the disease. Every year, up to 2.7 million new infections are registered worldwide. Up to 30 % of cases of HIV infection in pregnant women are detected for the first time during pregnancy-related examinations. Every year, 1.49 million babies are born to HIV-positive women worldwide. The current tasks are to preserve the health of women and reduce the risk of transmission of HIV infection from mother to child. The article analyzes the results of Russian and foreign studies concerning the problems of pregnant HIV-positive women, published in international databases. The aim of the work is to analyze the data of studies aimed at studying the effect of HIV infection on the course of pregnancy.
About the Authors
M. A. Rashidova
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
candidate of biological sciences
664003, Irkutsk, Timiryazev str., 16
L. F. Sholokhov
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
doctor of medical sciences, professor
664003, Irkutsk, Timiryazev str., 16
A. Yu. Marianian
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
doctor of medical sciences
664003, Irkutsk, Timiryazev str., 16
L. I. Kolesnikova
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
doctor of medical sciences, professor, academician of the RAS
664003, Irkutsk, Timiryazev str., 16
References
1. Spravka-VICH-v-Rossii-9-mes-2021-g..pdf Reference. HIV infection in the Russian Federation as of September 30, 2021. Available at: http://www.hivrussia.info/wp-content/uploads/2021/11/SpravkaVICH-v-Rossii-9-mes-2021-g..pdf [In Russian].
2. Pokrovsky: about 1.5 million people live with HIV in Russia. Available at: https://spid.center/ru/posts/4243/ [In Russian].
3. Nikitina O.A., Maryanyan A.Yu., Kolesnikova L.I. Oxidative stress in HIV infection and its effects on the female reproductive system and pregnancy. Zhurnal akusherstva i zhenskikh bolezney = Journal of Obstetrics and Women’s Diseases. 2020;69(4):61–72. [In Russian]. doi: 10.17816/JOWD69461-72
4. Statistics. Express information on the epidemic situation of HIV infection as of 07/01/2021 in the Irkutsk region. Available at: https://aids38.ru/?page_id=35 [In Russian].
5. Islam S., Oon V., Thomas P. Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy. J. Obstet. Gynaecol. 2010;30(1):38–40. doi: 10.3109/01443610903383358
6. Jao J., Sigel K.M., Chen K.T., Rodriguez-Caprio G., Posada R., Shust G., Wisniveskye J., Abrams E.J., Sperling R.S. Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV. AIDS. 2012;26(7):855–859. doi: 10.1097/QAD.0b013e-328351f6ef
7. Irkutsk Regional AIDS Center. Available at:: https://aids38.ru/ [In Russian].
8. Belyakov N.A., Vinogradova T.N. The role of the sexual route of HIV transmission in epidemic spread. VICH-infektsiya i immunosupressii = HIV Infection and Immunosuppression. 2011;3(4):7–19. [In Russian].
9. Leshchenko O.Ya., Genich E.V. Reproductive disorders and their pathogenetic mechanisms in women with HIV. VICH-infektsiya i immunosupressii = HIV Infection and Immunosuppression. 2019;11(4):20–29. [In Russian]. doi: 10.22328/2077-9828-2019-11-4-20-29
10. Drake A.L., Wagner A., Richardson B., JohnStewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: A systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001608. doi: 10.1371/journal.pmed.1001608
11. Liu K.C., Chibwesha C.J. Intrapartum management for prevention of mother-to-child transmission of HIV in resource-limited settings: a review of the literature. Afr. J. Reprod. Health. 2013;17(4 Spec No):107–117.
12. Govender T., Coovadia H. Eliminating mother to child transmission of HIV-1 and keeping mothers alive: Recent progress. J. Infect. 2014;68:57–62. doi: 10.1016/j.jinf.2013.09.015
13. Money D., Tulloch K., Boucoiran I., Caddy S., Infectious Diseases Committee; Special Contributors. Guidelines for the care of pregnant women living with HIV and interventions to reduce perinatal transmission: Executive summary. J. Obstet. Gynaecol. Can. 2014;36(8):721–734. doi: 10.1016/s1701-2163(15)30515-6
14. Osório D., Munyangaju I., Nacarapa E., Muhiwa A., Nhangave A.V., Ramos J.M. Mother-to-child transmission of HIV infection and its associated factors in the district of Bilene, Gaza Province–Mozambique. PLoS One. 2021;16(12):e0260941. doi: 10.1371/journal.pone.0260941
15. Shetty A.K., Maldonado Y. Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding. Curr. HIV Res. 2013;11(2):102–125. doi: 10.2174/1570162X11311020004
16. Brayfield B.P., Phiri S., Kankasa C., Muyanga J., Mantina H., Kwenda G., West J.T., Bhat G., Marx D.B., Klaskala W., Mitchell C.D., Wood C. Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. J. Infect. Dis. 2003; 187(4):559–568. doi: 10.1086/367985
17. Moodley D., Moodley J., Coovadia H., Gray G., McIntyre J., Hofmyer J., Nikodem C., Hall D., Gigliotti M., Robinson P., … South African Intrapartum Nevirapine Trial (SAINT) Investigators. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis. 2003;187(5):725–735. doi: 10.1086/367898
18. Johnson K.M., Alarcon J., Watts D.M., Rodriguez C., Velasquez C., Sanchez J., Lockhart D., Stoner B.P., Holmes K.K. Sexual networks of pregnant women with and without HIV infection. AIDS. 2003;17(4):605–612. doi: 10.1097/00002030-200303070-00016
19. Boonpongmanee C., Zauszniewski J.A., Morris D.L. Resourcefulness and self-care in pregnant women with HIV. West. J. Nurs. Res. 2003;25(1):75–92. doi: 10.1177/0193945902238837
20. Duff P. Prevention of opportunistic infections in women with HIV infection. Clin. Obstet. Gynecol. 2019;62(4):816–822. doi: 10.1097/GRF.0000000000000483
21. Verhofstede C., Demecheleer E., de Cabooter N., Gaillard P., Mwanyumba F., Claeys P., Chohan V., Mandaliya K., Temmerman M., Plum J. Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A. J. Virol. 2003;77(5):3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003
22. Makarov I.O., Shemanaeva T.V. The modern view of the management of pregnancy in HIV infection. Akusherstvo, ginekologiya i reproduktsiya = Obstetrics, Gynecology and Reproduction. 2012;6(2):31–34. [In Russian].
23. Dadhwal V., Sharma A., Khoiwal K., Deka D., Sarkar P., Vanamail P. Pregnancy outcomes in HIVinfected women: experience from a Tertiary Care Center in India. Int. J. MCH AIDS. 2017;6(1):75. doi: 10.21106/ijma.196
24. Kapetanovic S., Dass-Brailsford P., Nora D., Talisman N. Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review. AIDS Behav. 2014;18(6):1152–1173. doi: 10.1007/s10461-014-0728-9
25. Newell M.L., Huang S., Fiore S., Thorne C., Mandelbrot L., Sullivan J.L., Maupin R., Delke I., Watts D.H., Gelber R.D., Cunningham C.K., PACTG 316 Study Team. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect. Dis. 2007;7(1):60. doi: 10.1186/1471-2334-7-60
26. Kolesnikova L.I., Rashidova M.A., Darenskaya M.A., Sholokhov L.F., Grebenkina L.A., Semenova N.V. Parameters of oxidative stress of patients with parenteral viral hepatitises. Sibirskiy nauchnyy meditsinskiy zhurnal = Siberian Scientific Medical Journal. 2016;36(3):69–74. [In Russian].
27. Kolesnikova L.I., Semendyaev A.A., Stupin D.A., Darenskaya M.A., Grebenkina L.A., Natyaganova L.V., Kalyagin A.N., Shcherbatykh A.V., Petukhov A.A. On the opportunities of using the indices of lipid peroxidation – antioxidant defense system in the diagnostics of varicose veins of small pelvis in women. Acta Biomed. Sci. 2020;5(1): 14–20. [In Russian]. doi: 10.29413/ABS.2020-5.1.2
28. Kolesnikova L.I., Kolesnikov S.I., Darenskaya M.A., Grebenkina L.A., Timofeeva E.V., Leshchenko O.Ya., Vanteeva O.A., Rashidova M.A. Evaluation of the pro- and antioxidant status of women with HIV or coinfection. Terapevticheskiy arkhiv = Therapeutic Archive. 2016;88(11):17–21. [In Russian]. doi: 10.17116/terarkh2016881117-21.
29. Leshchenko O.Ya., Genich E.V., Darenskaya М.А., Kolesnikova L.I. HIV and infertility: neuro-endocrine and metabolic aspects. VICH-infekciya i immunosupressii = HIV Infection and Immunosuppressive Disorders. 2020;12(4): 73–80. [In Russian]. doi: 10.22328/2077-9828-2020-12-4-73-80
30. Gray G.E., McIntyre J.A. HIV and pregnancy. BMJ. 2007;334(7600):950–953. doi: 10.1136/bmj.39176.674977.ad
31. Mityurina E.V., Perminova S.G., Selimova F.N., Kozyrina N.V., Abubakirov A.N. Features of reproductive function realization in women with infertility and HIV infection in assisted reproductive technology programs. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2017;(10):70–77. [In Russian]. doi: 10.18565/aig.2017.10.70-77
32. Savasi V., Antonazzo P., Personeni C. Heterotopic pregnancy in HIV women. SAGE Open Med. Case Rep. 2016;4:2050313X16679534. doi: 10.1177/2050313x16679534
33. Medina-Marino A., Mudau M., Kojima N., Peters R.P., Feucht U.D., Vos L., Olivier D., Muzny C.A., McIntyre J.A., Klausner J.D. Persistent Chlamydia trachomatis, Neisseria gonorrhoeae or Trichomonas vaginalis positivity after treatment among human immunodeficiency virus-infected pregnant women, South Africa. Int. J. STD AIDS. 2020;31(4):294–302. doi: 10.1177/0956462419898612
34. Rimawi B.H., Smith S.L., Badell M.L., Zahedi-Spung L.D., Sheth A.N., Haddad L., Chakraborty R. HIV and reproductive healthcare in pregnant and postpartum HIV-infected women: adapting successful strategies. Future Virol. 2016;11(8):577–581. doi: 10.2217/fvl-2016-0065
35. Papp E., Mohammadi H., Loutfy M.R., Yudin M.H., Murphy K.E., Walmsley S.L., Shah R., MacGillivray J., Silverman M., Serghides L. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction. J. Infect. Dis. 2014;211(1):10–18. doi: 10.1093/infdis/jiu393
36. Conroy A.L., McDonald C.R., Gamble J.L., Olwoch P., Natureeba P., Cohan D., Kamya M.R., Havlir D.V., Dorsey G., Kain K.C. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am. J. Obstet. Gynecol. 2017;217(6):684. e1–684.e17. doi: 10.1016/j.ajog.2017.10.003
37. Newell M.L., Bunders M.J. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Curr. Opin. HIV AIDS. 2013;8(5):504–510. doi: 10.1097/coh.0b013e3283632b88
38. Zash R., Jacobson D.L., Diseko M., Mayondi G., Mmalane M., Essex M., Petlo C., Lockman S., Makhema J., Shapiro R.L. Comparative safety of antiretroviral treatment regimens in pregnancy. JAMA Pediatr. 2017;171(10):e172222. doi: 10.1001/jamapediatrics.2017.2222
39. Patel K., Shapiro D.E., Brogly S.B., Livingston E.G., Stek A.M., Bardeguez A.D., Tuomala R.E., P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group. Prenatal protease inhibitor use and risk of preterm birth among hiv‐infected women initiating antiretroviral drugs during pregnancy. J. Infect. Dis. 2010;201(7):1035–1044. doi: 10.1086/651232
40. Powis K.M., Kitch D., Ogwu A., Hughes M.D., Lockman S., Leidner J., van Widenfelt E., Moffat C., Moyo S., Makhema J., Essex M., Shapiro R.L. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J. Infect. Dis. 2011; 204(4):506–514. doi: 10.1093/infdis/jir307
41. Chen J.Y., Ribaudo H.J., Souda S., Parekh N., Ogwu A., Lockman S., Powis K., Dryden-Peterson S., Creek T., Jimbo W., … Shapiro R.L. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J. Infect. Dis. 2012;206(11):1695–1705. doi: 10.1093/infdis/jis553
42. Mofenson L.M. Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room? J. Infect. Dis. 2015;213(7):1051–1054. doi: 10.1093/infdis/jiv390
43. Powis K.M., Shapiro R.L. Protease inhibitors and adverse birth outcomes: is progesterone the missing piece to the puzzle? J. Infect. Dis. 2014;211(1):4–7. doi: 10.1093/infdis/jiu397
44. Li N., Sando M.M., Spiegelman D., Hertzmark E., Liu E., Sando D., Machumi L., Chalamilla G., Fawzi W. Antiretroviral therapy in relation to birth outcomes among HIV-infected women: a cohort study. J. Infect. Dis. 2015;213(7):1057–1064. doi: 10.1093/infdis/jiv389
45. Ravizza M., Martinelli P., Bucceri A., Fiore S., Alberico S., Tamburrini E., Tibaldi C., Guaraldi G., Anzidei G., … Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV‐infected pregnant women. J. Infect. Dis. 2007;195(6):913–914. doi: 10.1086/507045
46. Grosch-Woerner I., Puch K., Maier R.F., Niehues T., Notheis G., Patel D., Casteleyn S., FeiternaSperling C., Groeger S., Zaknun D., Multicenter Interdisciplinary Study Group Germany/Austria. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women. HIV Med. 2008; 9(1):6–13. doi: 10.1111/j.1468-1293.2008.00520.x
47. Van der Merwe K., Hoffman R., Black V., Chersich M., Coovadia A., Rees H. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J. Int. AIDS Soc. 2011;14(1):42. doi: 10.1186/1758-2652-14-42
48. Short C.-E., Douglas M., Smith J., Taylor G. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission. HIV Med. 2013; 15(4):233–238. doi: 10.1111/hiv.12083
49. Ekouevi D.K., Coffie P.A., Becquet R., Tonwe-Gold B., Horo A., Thiebaut R., Leroy V., Blanche S., Dabis F., Abrams E.J. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte dʼIvoire. AIDS. 2008;22(14):1815–1820. doi: 10.1097/qad.0b013e-32830b8ab9
50. Flynn P.M., Taha T.E., Cababasay M., Fowler M.G., Mofenson L.M., Owor M., Fiscus S., StranixChibanda L., Coutsoudis A., Gnanashanmugam D., … PROMISE Study Team. Prevention of HIV-1 transmission through breastfeeding. J. Acquir. Immune Defic. Syndr. 2018;77(4):383–392. doi: 10.1097/qai.0000000000001612
51. Sibiude J., Warszawski J., Tubiana R., Dollfus C., Faye A., Rouzioux C., Teglas J.P., Ekoukou D., Blanche S., Mandelbrot L. Premature delivery in HIVinfected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin. Infect. Dis. 2012; 54:1348–1360. doi: 10.1093/cid/cis198
52. Machado E.S., Hofer C.B., Costa T.T., Nogueira S.A., Oliveira R.H., Abreu T.F., Evangelista L.A., Farias I.F., Mercadante R.T., Garcia M.F., Neves R.C., Costa V.M., Lambert J.S. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception. Sex Transm. Infect. 2009; 85:82–87. doi: 10.1136/sti.2008.032300
53. Shteiman A.A., Okhapkin M.B. Features of haemodynamics in HIV-positive pregnant women. Terapevt = Therapist. 2015;(10):68–76. [In Russian].
54. Aaron E., Bonacquisti A., Mathew L., Alleyne G., Bamford L.P., Culhane J.F. Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy. Infect. Dis. Obstet. Gynecol. 2012:1–9. doi: 10.1155/2012/135030
55. Gorlenko A.V., Belykh O.A. The analysis of immunological indices in pregnant with HIV-infection. Immunologiya = Immunology. 2005;26(3):167–170. [In Russian].
56. Calvert C., Ronsmans C. Pregnancy and HIV disease progression: a systematic review and meta-analysis. Trop. Med. Int. Health. 2014;20(2):122–145. doi: 10.1111/tmi.12412
Review
For citations:
Rashidova M.A., Sholokhov L.F., Marianian A.Yu., Kolesnikova L.I. HIV and pregnancy: realities of XXI century. Сибирский научный медицинский журнал. 2022;42(2):10-17. (In Russ.) https://doi.org/10.18699/SSMJ20220202
Views:
532
Email this article 